EP1970050A1 — Intravenous emulsion of butylbenzene phthalein and its application
Assigned to CSPC NBP Pharmaceutical Co Ltd · Expires 2008-09-17 · 18y expired
What this patent protects
The present invention discloses a butylphthalide, intravenous emulsion for intravenous injection or infusion, containing butylphthalide, or derivatives thereof as an active ingredient in an amount of 0.01∼50wt% and an excipient in an amount of 50∼99.99wt%, based on the total weig…
USPTO Abstract
The present invention discloses a butylphthalide, intravenous emulsion for intravenous injection or infusion, containing butylphthalide, or derivatives thereof as an active ingredient in an amount of 0.01∼50wt% and an excipient in an amount of 50∼99.99wt%, based on the total weight of the emulsion.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.